Cannabis Use and Early Psychiatric Rehospitalization in Young Adults With Bipolar or Psychotic Disorders
medical cannabis research: A 200-patient historical cohort links cannabis use at psychiatric admission with higher early readmission risk, especially during the first month after discharge. It keeps the evidence readable for patients and clinicians. The…
THC and Social Behavior in Rodents Shows Dose, Timing, and Model Dependence
medical cannabis research: A systematic review of 49 rodent studies found THC often reduced normal social behavior, while low doses sometimes improved deficits in selected impairment models, with reporting quality limiting confidence. It keeps the…
Frequent Cannabis Use Linked With Higher Seizure Burden in Drug-Resistant Epilepsy
medical cannabis research: A small EMU cohort found frequent cannabis users with drug-resistant epilepsy had more focal to bilateral tonic-clonic seizures and greater medication burden, but the study cannot prove cannabis caused worse epilepsy. It keeps…
Virtual Family Coaching for Young Teens at Substance Use Risk Shows Feasibility, Not Proven Prevention
medical cannabis research: A tiny single-arm pilot found that a virtual 2-hour family session was acceptable and mostly completed, but it cannot yet prove reductions in teen cannabis, alcohol, tobacco use, or SUD risk. It keeps the evidence readable for…
New Headache Drug Targets Beyond CGRP: PACAP, Endocannabinoids, Sex Specific Pathways, and More
medical cannabis research: A 2025 narrative review maps emerging headache therapies beyond CGRP, including PACAP antibodies, endocannabinoid modulation, prolactin, orexin, PAR2, and nitroxidative stress targets. It keeps the evidence readable for…
CBD for Epilepsy Needs Evidence, Monitoring, and Better Trial Precision
medical cannabis research: A PubMed indexed review argues that cannabidiol has meaningful antiseizure potential in select refractory epilepsies, but its dosing, interactions, mechanisms, and long term safety still require careful clinical structure. It…
When One Substance Policy Changes Another Substance Use
medical cannabis research: A 95 study systematic review finds tobacco, cannabis, and alcohol policies often spill across substances, but substitution, complementarity, and independence vary by policy type and population. It keeps the evidence readable…
When Tobacco, Cannabis, and Alcohol Policies Spill Over Into Each Other
medical cannabis research: A 95-study systematic review finds that tobacco, cannabis, and alcohol policies often influence use of other substances, but the direction depends on policy type, population, and substance pairing. It keeps the evidence…
When Cannabis, Alcohol, and Tobacco Policies Collide
medical cannabis research: A 95-study systematic review finds that substance policies often spill across cannabis, alcohol, and tobacco use, but the direction depends heavily on policy type, population, and substance pairing. It keeps the evidence…
When Cannabis, Tobacco, and Alcohol Policies Collide
medical cannabis research: A 95-study systematic review finds that policies aimed at one substance often influence use of others, but the direction of change depends heavily on policy type, population, and context. It keeps the evidence readable for…
